Skip to main content
Home / Current Pharmaceutical Design, Volume 19, Number 18
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 19, Number 18, 2013

Articles

Editorial(Hot Topic:Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future Directions)
pp. 3173-3174(2)
Author: Mao, Xinliang

Favourites:
ADD

Emerging Role of the Ubiquitin-proteasome System as Drug Targets
pp. 3175-3189(15)
Authors: Kar, Gozde; Keskin, Ozlem; Fraternali, Franca; Gursoy, Attila

Favourites:
ADD

Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
pp. 3190-3200(11)
Authors: Cao, Biyin; Li, Jie; Mao, Xinliang

Favourites:
ADD

Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy
pp. 3201-3209(9)
Authors: Xu, Wei; Lukkarila, Julie L.; da Silva, Sara R.; Paiva, Stacey-Lynn; Gunning, Patrick T.; Schimmer, Aaron D.

Favourites:
ADD

Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
pp. 3210-3214(5)
Authors: Wang, Zhiwei; Wan, Lixin; Zhong, Jiateng; Inuzuka, Hiroyuki; Liu, Pengda; Sarkar, Fazlul H.; Wei, Wenyi

Favourites:
ADD

Cullin-RING Ligases as Attractive Anti-cancer Targets
pp. 3215-3225(11)
Authors: Zhao, Yongchao; Sun, Yi

Favourites:
ADD

Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1
pp. 3226-3233(8)
Authors: Cao, Yu; Zhang, Lingqiang

Favourites:
ADD

Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases
pp. 3234-3247(14)
Authors: Nanduri, Bindu; Suvarnapunya, Akamol E.; Venkatesan, Malabi; Edelmann, Mariola J.

Favourites:
ADD

Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
pp. 3248-3262(15)
Authors: DeVine, Tiffany; Dai, Mu-Shui

Favourites:
ADD

When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
pp. 3263-3275(13)
Authors: Wu, Zhao-Hui; Shi, Yuling

Favourites:
ADD

Regulation of Skeletal Muscle Plasticity by Glycogen Synthase Kinase-3beta;: A Potential Target for the Treatment of Muscle Wasting
pp. 3276-3298(23)
Authors: Verhees, Koen J.P.; Pansters, Nicholas A.M.; Schols, Annemie M.W.J.; Langen, Ramon C.J.

Favourites:
ADD

Proteasome Inhibition in Transplantation-Focusing on the Experience with Bortezomib
pp. 3299-3304(6)
Authors: Liang, Yong; Liu, Haiyan

Favourites:
ADD

The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases
pp. 3305-3314(10)
Authors: Ying, Zheng; Wang, Hongfeng; Wang, Guanghui

Favourites:
ADD

Comprehensive Profiling of Protein Ubiquitination for Drug Discovery
pp. 3315-3328(14)
Authors: Xu, Guoqiang; Jaffrey, Samie R.

Favourites:
ADD

An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
pp. 3329-3341(13)
Authors: Yu, Zilin; Ananias, Hildo J. K.; Carlucci, Giuseppe; Hoving, Hilde D.; Helfrich, Wijnand; Dierckx, Rudi A.J.O.; Wang, Fan; Jong, Igle J. de; Elsinga, Philip H.

Favourites:
ADD

Ultrasound-Based Multimodal Molecular Imaging and Functional Ultrasound Contrast Agents
pp. 3342-3351(10)
Authors: Lin, Yan; Chen, Zhi-Yi; Yang, Feng

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content